Evidence map›Paper›PMID 23685087›Full record

ReviewMolecular aspects of medicine2014

Biosynthesis and trafficking of the bile salt export pump, BSEP: therapeutic implications of BSEP mutations.

Carol J Soroka, James L Boyer

Abstract readReview
In one paragraph

Review in Molecular aspects of medicine, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed, 2 pooled it
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 2 syntheses or guidelines pooled it, 90 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Review
  5. Farnesoid x Receptor Deficiency Promotes Hepatocytic Injury in Cyp2c70-Deficient Mice With a Human-Like Bile Acid Composition.Liver international : official journal of the International Association for the Study of the Liver · 2026
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Development of anFrontiers in pharmacology · 2025
    Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Chishao (Frontiers in pharmacology · 2024
    Article
  16. Article
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Carol J SorokaYale University School of Medicine, Department of Internal Medicine, New Haven, CT 06520, United States. Electronic address: carol.soroka@yale.edu.
James L BoyerYale University School of Medicine, Department of Internal Medicine, New Haven, CT 06520, United States. Electronic address: james.boyer@yale.edu.
Yale University · US

Funding

Yale Liver CenterP30DK034989 · NIDDK · YALE UNIVERSITY · PI YASUKO IWAKIRI · 1986 to 2026
$31.1M
MECHANISMS OF BILE SECRETION &CHOLESTASISR37DK025636 · NIDDK · YALE UNIVERSITY · PI BOYER, JAMES LORENZEN · 1990 to 2017
$9.7M
MECHANISMS OF BILE SECRETION AND CHOLESTASISR01DK025636 · NIDDK · YALE UNIVERSITY · PI BOYER, JAMES LORENZEN · 1986 to 2007
$6.1M
NIDDK NIH HHS P30 DK034989NIDDK NIH HHS P30 DK 34989NIDDK NIH HHS R01 DK025636NIDDK NIH HHS R37 DK025636NIDDK NIH HHS R37 DK25636
6 · The paper itself

Abstract

The bile salt export pump (BSEP, ABCB11) is the primary transporter of bile acids from the hepatocyte to the biliary system. This rate-limiting step in bile formation is essential to the formation of bile salt dependent bile flow, the enterohepatic circulation of bile acids, and the digestion of dietary fats. Mutations in BSEP are associated with cholestatic diseases such as progressive familial intrahepatic cholestasis type 2 (PFIC2), benign recurrent intrahepatic cholestasis type 2 (BRIC2), drug-induced cholestasis, and intrahepatic cholestasis of pregnancy. Development of clinical therapies for these conditions necessitates a clear understanding of the cell biology of biosynthesis, trafficking, and transcriptional and translational regulation of BSEP. This chapter will focus on the molecular and cell biological aspects of this critical hepatic membrane transporter.

Indexed as

ATP-Binding Cassette TransportersATP Binding Cassette Transporter, Subfamily B, Member 11Bile Acids and SaltsBiliary TractCholestasis, IntrahepaticFemaleHepatocytesHumansMutationPregnancyABCB11 protein, humanATP-Binding Cassette TransportersATP Binding Cassette Transporter, Subfamily B, Member 11Bile Acids and SaltsATP-binding cassette transporterBile salt secretionCholestasis

Identifiers

PMID23685087
PMCPMC3784619
OpenAlexW2020943087

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.